WHO has issued an urgent medical product alert regarding falsified semaglutides, a class of medications used primarily in the treatment of type 2 diabetes and, increasingly, for weight management.The post WHO issues medical alert on falsified Ozempic, diabetes medications after NAFDAC issues same appeared first on Nairametrics.
Related Articles
Don't miss out on breaking stories and in-depth articles.